|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arbyn M, Weiderpass E, Bruni L, de Sanjosé
S, Saraiya M, Ferlay J and Bray F: Estimates of incidence and
mortality of cervical cancer in 2018: A worldwide analysis. Lancet
Glob Health. 8:e191–e203. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nagase S, Ohta T, Takahashi F and Yaegashi
N; Board members of the 2020 Committee on Gynecologic Oncology of
the Japan Society of Obstetrics and Gynecology, : Annual report of
the committee on gynecologic oncology, the japan society of
obstetrics and gynecology: Annual patient report for 2017 and
annual treatment report for 2012. J Obstet Gynaecol Res.
47:1631–1642. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vizcaino AP, Moreno V, Bosch FX, Muñoz N,
Barros-Dios XM, Borras J and Parkin DM: International trends in
incidence of cervical cancer: II. Squamous-cell carcinoma. Int J
Cancer. 86:429–435. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Quinn M, Babb P, Jones J and Allen E:
Effect of screening on incidence of and mortality from cancer of
cervix in England: Evaluation based on routinely collected
statistics. BMJ. 318:904–908. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Soutter WP, de Barros Lopes A, Fletcher A,
Monaghan JM, Duncan ID, Paraskevaidis E and Kitchener HC: Invasive
cervical cancer after conservative therapy for cervical
intraepithelial neoplasia. Lancet. 349:978–980. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Arbyn M, Xu L, Simoens C and Martin-Hirsch
PP: Prophylactic vaccination against human papillomaviruses to
prevent cervical cancer and its precursors. Cochrane Database Syst
Rev. 5:CD0090692018.PubMed/NCBI
|
|
8
|
Lees BF, Erickson BK and Huh WK: Cervical
cancer screening: Evidence behind the guidelines. Am J Obstet
Gynecol. 214:438–443. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yuri S, Osamu I, Ichiro A, Takuya M,
Yoshiki M, Kuniko I and Ryo K: Cervical cancer screening with human
papillomavirus DNA and cytology in Japan. Int J Gynecol Cancer.
27:523–529. 2017. View Article : Google Scholar
|
|
10
|
Hashiguchi M, Nakao Y, Honda A, Kawaguchi
A, Hanashima K, Nishiyama S and Yokoyama M: What has changed since
the introduction of human papillomavirus testing with the
cytology-based cervical cancer screening system in Japan a social
experiment. Acta Cytol. 63:385–390. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barroeta JE, Adhikari-Guragain D and
Grotkowski CE: Cervical cancer screening in the era of HPV
vaccination: A review of shifting paradigms in cytopathology. Diagn
Cytopathol. 45:903–914. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bosch FX and de Sanjosé S: Chapter 1:
Human papillomavirus and cervical cancer-burden and assessment of
causality. J Natl Cancer Inst Monogr. 2003:3–13. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huh WK, Ault KA, Chelmow D, Davey DD,
Goulart RA, Garcia FA, Kinney WK, Massad LS, Mayeaux EJ, Saslow D,
et al: Use of primary high-risk human papillomavirus testing for
cervical cancer screening: Interim clinical guidance. Gynecol
Oncol. 136:178–182. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tao X, Zhang H, Wang L, Pan Q, Ji S, Zhou
X and Zhao C: Atypical squamous cells of undetermined significance
cervical cytology in the Chinese population: Age-stratified
reporting rates, high-risk HPV testing, and immediate histologic
correlation results. Cancer Cytopathol. 129:24–32. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Massad LS, Einstein MH, Huh WK, Katki HA,
Kinney WK, Schiffman M, Solomon D, Wentzensen N and Lawson HW; 2012
ASCCP Consensus Guidelines Conference, : 2012 updated consensus
guidelines for the management of abnormal cervical cancer screening
tests and cancer precursors. Obstet Gynecol. 121:829–846. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aro K, Nieminen P, Louvanto K, Jakobsson
M, Virtanen S, Lehtinen M, Dillner J and Kalliala I: Age-specific
HPV type distribution in high-grade cervical disease in screened
and unvaccinated women. Gynecol Oncol. 154:354–359. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Giannella L, Delli Carpini G, Di Giuseppe
J, Prandi S, Tsiroglou D and Ciavattini A: Age-related changes in
the fraction of cervical intraepithelial neoplasia grade 3 related
to HPV genotypes included in the nonavalent vaccine. J Oncol.
2019:71378912019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bao H, Ma L, Zhao Y, Song B, Di J, Wang L,
Gao Y, Ren W, Wang S, Wu J and Wang HJ: Age-specific effectiveness
of primary human papillomavirus screening versus cytology in a
cervical cancer screening program: A nationwide cross-sectional
study. Cancer Commun (Lond). 42:191–204. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Agorastos T, Chatzistamatiou K,
Katsamagkas T, Koliopoulos G, Daponte A, Constantinidis T and
Constantinidis TC; HERMES study group, : Primary screening for
cervical cancer based on high-risk human papillomavirus (HPV)
detection and HPV 16 and HPV 18 genotyping, in comparison to
cytology. PLoS One. 10:e01197552015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yagi A, Ueda Y, Nakagawa S, Ikeda S,
Tanaka Y, Sekine M, Miyagi E, Enomoto T and Kimura T: Potential for
cervical cancer incidence and death resulting from Japan's current
policy of prolonged suspension of its governmental recommendation
of the HPV vaccine. Sci Rep. 10:159452020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yagi A, Ueda Y, Kakuda M, Nakagawa S,
Hiramatsu K, Miyoshi A, Kobayashi E, Kimura T, Kurosawa M,
Yamaguchi M, et al: Cervical cancer protection in Japan: Where are
we? Vaccines (Basel). 9:12632021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sekine M, Kudo R, Adachi S, Yamaguchi M,
Ueda Y, Takata T, Morimoto A, Tanaka Y, Yagi A, Miyagi E and
Enomoto T: Japanese crisis of HPV vaccination. Int J Pathol Clin
Res. 2:392016. View Article : Google Scholar
|
|
23
|
Yagi A, Ueda Y, Ikeda S, Miyagi E, Sekine
M, Enomoto T and Kimura T: The looming health hazard: A wave of
HPV-related cancers in Japan is becoming a reality due to the
continued suspension of the governmental recommendation of HPV
vaccine. Lancet Reg Health West Pac. 18:1003272021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Solomon D, Davey D, Kurman R, Moriarty A,
O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, et
al: The 2001 Bethesda system: Terminology for reporting results of
cervical cytology. JAMA. 287:2114–2119. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Onuki M, Matsumoto K, Satoh T, Oki A,
Okada S, Minaguchi T, Ochi H, Makao S, Someya K, Yamada N, et al:
Human papillomavirus infections among Japanese women: Age-related
prevalence and type-specific risk for cervical cancer. Cancer Sci.
100:1312–1316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vänskä S, Luostarinen T, Lagheden C,
Eklund C, Kleppe SN, Andrae B, Sparén P, Sundström K, Lehtinen M
and Dillner J: Differing age-specific cervical cancer incidence
between different types of human papillomavirus: Implications for
predicting the impact of elimination programs. Am J Epidemiol.
190:506–514. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
de Sanjose S, Wheeler CM, Quint WGV, Hunt
WC, Joste NE, Alemany L, Bosch FX; Retrospective International
Survey and HPV Time Trends Study Group, ; Myers ER and Castle PE:
Age-specific occurrence of HPV16- and HPV18-related cervical
cancer. Cancer Epidemiol Biomarkers Prev. 22:1313–1318. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hammer A, Rositch A, Qeadan F, Gravitt PE
and Blaakaer J: Age-specific prevalence of HPV16/18 genotypes in
cervical cancer: A systematic review and meta-analysis. Int J
Cancer. 138:2795–2803. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Burger EA, Kim JJ, Sy S and Castle PE: Age
of acquiring causal human papillomavirus (HPV) infections:
Leveraging simulation models to explore the natural history of
HPV-induced cervical cancer. Clin Infect Dis. 65:893–899. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Baasland I, Hagen B, Vogt C, Valla M and
Romundstad PR: Colposcopy and additive diagnostic value of biopsies
from colposcopy-negative areas to detect cervical dysplasia. Acta
Obstet Gynecol Scand. 95:1258–1263. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tatiyachonwiphut M, Jaishuen A, Sangkarat
S, Laiwejpithaya S, Wongtiraporn W, Inthasorn P, Viriyapak B and
Warnnissorn M: Agreement between colposcopic diagnosis and cervical
pathology: Siriraj hospital experience. Asian Pac J Cancer Prev.
15:423–426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rebolj M, Pesola F, Mathews C, Mesher D,
Soldan K and Kitchener H: The impact of catch-up bivalent human
papillomavirus vaccination on cervical screening outcomes: An
observational study from the English HPV primary screening pilot.
Br J Cancer. 127:278–287. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hiramatsu K, Ueda Y, Yagi A, Morimoto A,
Egawa-Takata T, Nakagawa S, Kobayashi E, Kimura T, Kimura T,
Minekawa R, et al: The efficacy of human papillomavirus vaccination
in young Japanese girls: The interim results of the OCEAN study.
Hum Vaccin Immunother. 18:19510982022. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kyrgiou M, Athanasiou A, Paraskevaidi M,
Mitra A, Kalliala I, Martin-Hirsch P, Arbyn M, Bennett P and
Paraskevaidis E: Adverse obstetric outcomes after local treatment
for cervical preinvasive and early invasive disease according to
cone depth: Systematic review and meta-analysis. BMJ.
354:i36332016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Arbyn M, Kyrgiou M, Simoens C, Raifu AO,
Koliopoulos G, Martin-Hirsch P, Prendiville W and Paraskevaidis E:
Perinatal mortality and other severe adverse pregnancy outcomes
associated with treatment of cervical intraepithelial neoplasia:
Meta-analysis. BMJ. 337:a12842008. View Article : Google Scholar : PubMed/NCBI
|
